Search

Pharmaceutical Forms: 50, 150 and 200 mg x 120 hard capsules

Therapeutic Area: Oncohematology

Active Ingredient: Nilotinib

Pharmaceutical Forms: 100 mg x 28 coated tablets
400 mg x 28 coated tablets
500 mg x 28 coated tablets

Therapeutic Area: Antineoplastic + Oncohematology + Protein Kinase Inhibitor

Active Ingredient: Bosutinib

Pharmaceutical Forms: 140 mg x 90 hard capsules and 120 hard capsules

Therapeutic Area: Oncohematology

Active Ingredient: Ibrutinib

Pharmaceutical Forms: Solution 10 mg/ml.
1 vial x 50 ml (500 mg)
2 vials x 10ml (100 mg)

Therapeutic Area: Oncohematology + Oncology + Rheumatology

Active Ingredient: Rituximab

Pharmaceutical Forms: 60 mg lyophilized power x 1 vial

Therapeutic Area: Oncohematology

Active Ingredient: Carfilzomib